199 related articles for article (PubMed ID: 18196642)
41. Beta-blockers post-MI: an example of age discrimination?
Gottlieb S
Postgrad Med; 2002 Dec; 112(6 Suppl Heart):28-33. PubMed ID: 19667615
[TBL] [Abstract][Full Text] [Related]
42. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
Vincent GM; Schwartz PJ; Denjoy I; Swan H; Bithell C; Spazzolini C; Crotti L; Piippo K; Lupoglazoff JM; Villain E; Priori SG; Napolitano C; Zhang L
Circulation; 2009 Jan; 119(2):215-21. PubMed ID: 19118258
[TBL] [Abstract][Full Text] [Related]
43. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
[TBL] [Abstract][Full Text] [Related]
45. Current endoscopic therapy of variceal bleeding.
Villanueva C; Colomo A; Aracil C; Guarner C
Best Pract Res Clin Gastroenterol; 2008; 22(2):261-78. PubMed ID: 18346683
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
47. Beta-blockers should remain as first-line therapy in the management of hypertension.
Krum H
Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
[No Abstract] [Full Text] [Related]
48. [Differential therapy with beta-adrenergic blockers].
Rumboldt Z
Lijec Vjesn; 1984; 106(11-12):494-7. PubMed ID: 6151617
[No Abstract] [Full Text] [Related]
49. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary effects of nebivolol.
Dal Negro R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
[TBL] [Abstract][Full Text] [Related]
51. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
52. [Adverse effects and toxicity of beta blockers].
Bosković B; Dobrić S; Stojiljković MP
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():74-80. PubMed ID: 18193817
[TBL] [Abstract][Full Text] [Related]
53. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
Kountz DS
Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
[TBL] [Abstract][Full Text] [Related]
54. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
55. Ahlquist and the development of beta-adrenoceptor antagonists.
Black JW
Postgrad Med J; 1976; 52 Suppl 4():11-13. PubMed ID: 9627
[TBL] [Abstract][Full Text] [Related]
56. beta(1)-adrenoceptor polymorphisms: deviation of clinical outcome with use of beta-blockers in ventricular dysfunction.
Tabrizchi R
Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):145-7. PubMed ID: 18248268
[TBL] [Abstract][Full Text] [Related]
57. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
Hansen ML; Gadsbøll N; Gislason GH; Abildstrom SZ; Schramm TK; Folke F; Friberg J; Sørensen R; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
Europace; 2008 Apr; 10(4):395-402. PubMed ID: 18258807
[TBL] [Abstract][Full Text] [Related]
58. [Application of beta blockers in ophthalmology].
Cvetković D
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():51-3. PubMed ID: 18193811
[TBL] [Abstract][Full Text] [Related]
59. Beta-blockers and heart failure: from maverick idea to gold-standard treatment.
Wilkinson E
Eur Heart J; 2009 Apr; 30(7):744-6. PubMed ID: 19348065
[TBL] [Abstract][Full Text] [Related]
60. Is the coprescription of beta blockers and beta2 agonists justified in COPD?
Singh A
Thorax; 2008 Nov; 63(11):1026; author reply 1026. PubMed ID: 18984821
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
